vs
Side-by-side financial comparison of AstroNova, Inc. (ALOT) and SBC Medical Group Holdings Inc (SBC). Click either name above to swap in a different company.
SBC Medical Group Holdings Inc is the larger business by last-quarter revenue ($39.6M vs $39.2M, roughly 1.0× AstroNova, Inc.). SBC Medical Group Holdings Inc runs the higher net margin — 35.9% vs 1.0%, a 34.9% gap on every dollar of revenue. On growth, AstroNova, Inc. posted the faster year-over-year revenue change (-3.4% vs -10.9%). SBC Medical Group Holdings Inc produced more free cash flow last quarter ($51.2M vs $3.3M). Over the past eight quarters, AstroNova, Inc.'s revenue compounded faster (2.1% CAGR vs -15.0%).
AstroNova, Inc. is a global technology firm designing, manufacturing and distributing specialty data visualization products, including high-performance label printers, test and measurement equipment, and aerospace-grade data recording systems, serving aerospace, manufacturing, retail and healthcare markets worldwide.
SBC Medical Group Holdings Inc. is a leading Japan-headquartered healthcare provider primarily focused on aesthetic medicine, dermatology, and anti-aging wellness services. It operates an extensive network of clinics across Japan, catering to both domestic patients and international medical tourists, with core offerings including cosmetic surgery and non-invasive skincare treatments.
ALOT vs SBC — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $39.2M | $39.6M |
| Net Profit | $378.0K | $14.2M |
| Gross Margin | 36.2% | 73.1% |
| Operating Margin | 3.3% | 32.5% |
| Net Margin | 1.0% | 35.9% |
| Revenue YoY | -3.4% | -10.9% |
| Net Profit YoY | 221.5% | 117.2% |
| EPS (diluted) | $0.05 | $0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $39.2M | $39.6M | ||
| Q3 25 | $36.1M | $43.4M | ||
| Q2 25 | $37.7M | $43.4M | ||
| Q1 25 | — | $47.3M | ||
| Q4 24 | $40.4M | $44.4M | ||
| Q3 24 | $40.5M | $53.1M | ||
| Q2 24 | $33.0M | $53.1M | ||
| Q1 24 | $39.6M | $54.8M |
| Q4 25 | $378.0K | $14.2M | ||
| Q3 25 | $-1.2M | $12.8M | ||
| Q2 25 | $-376.0K | $2.5M | ||
| Q1 25 | — | $21.5M | ||
| Q4 24 | $240.0K | $6.5M | ||
| Q3 24 | $-311.0K | $2.8M | ||
| Q2 24 | $1.2M | $18.5M | ||
| Q1 24 | $2.7M | $18.8M |
| Q4 25 | 36.2% | 73.1% | ||
| Q3 25 | 32.2% | 70.6% | ||
| Q2 25 | 33.6% | 69.2% | ||
| Q1 25 | — | 79.7% | ||
| Q4 24 | 33.9% | 76.3% | ||
| Q3 24 | 35.3% | 81.5% | ||
| Q2 24 | 36.3% | 74.2% | ||
| Q1 24 | 31.9% | 72.1% |
| Q4 25 | 3.3% | 32.5% | ||
| Q3 25 | -2.0% | 36.6% | ||
| Q2 25 | 1.5% | 33.6% | ||
| Q1 25 | — | 51.1% | ||
| Q4 24 | 3.1% | 10.6% | ||
| Q3 24 | 2.6% | 26.1% | ||
| Q2 24 | 4.1% | 51.4% | ||
| Q1 24 | 9.9% | 44.6% |
| Q4 25 | 1.0% | 35.9% | ||
| Q3 25 | -3.4% | 29.6% | ||
| Q2 25 | -1.0% | 5.7% | ||
| Q1 25 | — | 45.4% | ||
| Q4 24 | 0.6% | 14.7% | ||
| Q3 24 | -0.8% | 5.3% | ||
| Q2 24 | 3.6% | 34.8% | ||
| Q1 24 | 6.8% | 34.2% |
| Q4 25 | $0.05 | $0.15 | ||
| Q3 25 | $-0.16 | $0.12 | ||
| Q2 25 | $-0.05 | $0.02 | ||
| Q1 25 | — | $0.21 | ||
| Q4 24 | $0.03 | $0.05 | ||
| Q3 24 | $-0.04 | $0.03 | ||
| Q2 24 | $0.15 | $0.20 | ||
| Q1 24 | $0.37 | $0.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.6M | $164.1M |
| Total DebtLower is stronger | — | $42.8M |
| Stockholders' EquityBook value | $76.9M | $248.3M |
| Total Assets | $140.8M | $380.4M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.6M | $164.1M | ||
| Q3 25 | $3.9M | $127.4M | ||
| Q2 25 | $5.4M | $152.7M | ||
| Q1 25 | — | $132.1M | ||
| Q4 24 | $4.4M | $125.0M | ||
| Q3 24 | $4.8M | $137.4M | ||
| Q2 24 | $4.0M | — | ||
| Q1 24 | $4.5M | — |
| Q4 25 | — | $42.8M | ||
| Q3 25 | — | $21.1M | ||
| Q2 25 | — | $7.1M | ||
| Q1 25 | — | $6.9M | ||
| Q4 24 | — | $6.6M | ||
| Q3 24 | — | $823.2K | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $76.9M | $248.3M | ||
| Q3 25 | $75.8M | $248.0M | ||
| Q2 25 | $76.6M | $244.6M | ||
| Q1 25 | — | $226.4M | ||
| Q4 24 | $92.2M | $195.1M | ||
| Q3 24 | $91.8M | $205.0M | ||
| Q2 24 | $91.2M | $8.8M | ||
| Q1 24 | $90.3M | $9.0M |
| Q4 25 | $140.8M | $380.4M | ||
| Q3 25 | $143.1M | $321.4M | ||
| Q2 25 | $150.3M | $315.3M | ||
| Q1 25 | — | $284.6M | ||
| Q4 24 | $166.5M | $266.1M | ||
| Q3 24 | $169.0M | $296.5M | ||
| Q2 24 | $126.6M | $19.5M | ||
| Q1 24 | $133.3M | $19.8M |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.09× | ||
| Q2 25 | — | 0.03× | ||
| Q1 25 | — | 0.03× | ||
| Q4 24 | — | 0.03× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $3.4M | $52.0M |
| Free Cash FlowOCF − Capex | $3.3M | $51.2M |
| FCF MarginFCF / Revenue | 8.5% | 129.3% |
| Capex IntensityCapex / Revenue | 0.2% | 2.0% |
| Cash ConversionOCF / Net Profit | 9.05× | 3.66× |
| TTM Free Cash FlowTrailing 4 quarters | $2.9M | $23.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.4M | $52.0M | ||
| Q3 25 | $249.0K | $-20.9M | ||
| Q2 25 | $4.4M | $-8.3M | ||
| Q1 25 | — | $1.9M | ||
| Q4 24 | $-4.7M | $-7.3M | ||
| Q3 24 | $162.0K | $5.0M | ||
| Q2 24 | $6.9M | $19.2M | ||
| Q1 24 | $6.5M | $3.7M |
| Q4 25 | $3.3M | $51.2M | ||
| Q3 25 | $202.0K | $-20.9M | ||
| Q2 25 | $4.3M | $-8.6M | ||
| Q1 25 | — | $1.7M | ||
| Q4 24 | $-5.0M | $-7.9M | ||
| Q3 24 | $-176.0K | $4.6M | ||
| Q2 24 | $6.4M | $18.3M | ||
| Q1 24 | $6.0M | $3.0M |
| Q4 25 | 8.5% | 129.3% | ||
| Q3 25 | 0.6% | -48.3% | ||
| Q2 25 | 11.5% | -19.9% | ||
| Q1 25 | — | 3.5% | ||
| Q4 24 | -12.4% | -17.8% | ||
| Q3 24 | -0.4% | 8.7% | ||
| Q2 24 | 19.5% | 34.5% | ||
| Q1 24 | 15.3% | 5.4% |
| Q4 25 | 0.2% | 2.0% | ||
| Q3 25 | 0.1% | 0.1% | ||
| Q2 25 | 0.2% | 0.7% | ||
| Q1 25 | — | 0.5% | ||
| Q4 24 | 0.6% | 1.3% | ||
| Q3 24 | 0.8% | 0.8% | ||
| Q2 24 | 1.5% | 1.6% | ||
| Q1 24 | 1.0% | 1.3% |
| Q4 25 | 9.05× | 3.66× | ||
| Q3 25 | — | -1.63× | ||
| Q2 25 | — | -3.39× | ||
| Q1 25 | — | 0.09× | ||
| Q4 24 | -19.76× | -1.12× | ||
| Q3 24 | — | 1.77× | ||
| Q2 24 | 5.85× | 1.04× | ||
| Q1 24 | 2.38× | 0.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ALOT
| Public Utilities Inventory Supplies | $20.6M | 53% |
| Hardware Products | $12.7M | 32% |
| Service And Other | $5.9M | 15% |
SBC
| Franchising | $10.3M | 26% |
| Medical Corporation Shobikai | $8.1M | 21% |
| Medical Corporation Nasukai | $7.2M | 18% |
| Management Services | $6.3M | 16% |
| Rental Services | $4.3M | 11% |
| Medical Corporation Association Furinkai | $3.0M | 8% |
| Japan Medical And Beauty Inc | $656.5K | 2% |
